Chapter 12
Role of the AHR and its Structure in TCDD Toxicity
Raimo Pohjanvirta,
Merja Korkalainen,
Ivy D. Moffat,
Paul C. Boutros,
Allan B. Okey,
Raimo Pohjanvirta
Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
Search for more papers by this authorMerja Korkalainen
Department of Environmental Health, National Institute for Health and Welfare, Kuopio, Finland
Search for more papers by this authorIvy D. Moffat
Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
Search for more papers by this authorPaul C. Boutros
Informatics and Biocomputing Platform, Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada
Search for more papers by this authorAllan B. Okey
Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
Search for more papers by this authorRaimo Pohjanvirta,
Merja Korkalainen,
Ivy D. Moffat,
Paul C. Boutros,
Allan B. Okey,
Raimo Pohjanvirta
Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
Search for more papers by this authorMerja Korkalainen
Department of Environmental Health, National Institute for Health and Welfare, Kuopio, Finland
Search for more papers by this authorIvy D. Moffat
Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
Search for more papers by this authorPaul C. Boutros
Informatics and Biocomputing Platform, Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada
Search for more papers by this authorAllan B. Okey
Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
Search for more papers by this authorBook Editor(s):Raimo Pohjanvirta,
Raimo Pohjanvirta
Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Introduction
-
Toxicity of TCDD
-
Ligand Binding Domain
-
Transactivation Domain
-
Conclusions
-
Acknowledgments
-
References
REFERENCES
- Poland, A. and Glover, E. (1974). Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a potent inducer of aryl hydro-carbon hydroxylase, with 3-methylcholanthrene. Molecular Pharmacology, 10, 349–359.
- Poland, A., Glover, E., and Kende, A. S. (1976). Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. Journal of Biological Chemistry, 251, 4936–4946.
- McIntosh, B. E., Hogenesch, J. B., and Bradfield, C. A. (2010). Mammalian Per–Arnt–Sim proteins in environmental adaptation. Annual Review of Physiology, 72, 625–645.
- Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. Journal of Biological Chemistry, 279, 23847–23850.
- Kimmig, J. and Schulz, K. H. (1957). Chlorierte aromatische zyklische Äther als Ursache der sogenannten Chlorakne. Natürwissenschaften, 44, 337–338.
- Pohjanvirta, R. and Tuomisto, J. (1994). Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacological Reviews, 46, 483–549.
- Poland, A. and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology, 22, 517–554.
- Birnbaum, L. S. and Tuomisto, J. (2000). Non-carcinogenic effects of TCDD in animals. Food Additives and Contaminants, 17, 275–288.
- Schwetz, B. A., Norris, J. M., Sparschu, G. L., Rowe, U. K., Gehring, P. J., Emerson, J. L., and Gerbig, C. G. (1973). Toxicology of chlorinated dibenzo-p-dioxins. Environmental Health Perspectives, 5, 87–99.
- Henck, J. M., New, M. A., Kociba, R. J., and Rao, K. S. (1981). 2,3,7,8-Tetrachlorodibenzo-p-dioxin: acute oral toxicity in hamsters. Toxicology and Applied Pharmacology, 59, 405–407.
- Pohjanvirta, R., Unkila, M., and Tuomisto, J. (1993). Comparative acute lethality of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in the most TCDD-susceptible and the most TCDD-resistant rat strain. Pharmacology & Toxicology, 73, 52–56.
- Unkila, M., Pohjanvirta, R., MacDonald, E., Tuomisto, J. T., and Tuomisto, J. (1994). Dose response and time course of alterations in tryptophan metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-susceptible and the most TCDD-resistant rat strain: relationship with TCDD lethality. Toxicology and Applied Pharmacology, 128, 280–292.
- Pohjanvirta, R., Boutros, P.C., Moffat, I. D., Linden, J., Wendelin, D., and Okey, A. B. (2008). Genome-wide effects of acute progressive feed restriction in liver and white adipose tissue. Toxicology and Applied Pharmacology, 230, 41–56.
- Simanainen, U., Tuomisto, J. T., Pohjanvirta, R., Syrjala, P., Tuomisto, J., and Viluksela, M. (2004). Postnatal development of resistance to short-term high-dose toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in TCDD-resistant and -semiresistant rats. Toxicology and Applied Pharmacology, 196, 11–19.
- Linden, J., Lensu, S., Tuomisto, J., and Pohjanvirta, R. (2010). Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance. Frontiers in Neuroendocrinology, 31, 452–478.
- Christian, B. J., Inhorn, S. L., and Peterson, R. E. (1986). Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 82, 239–255.
- Weber, L. W., Lebofsky, M., Stahl, B. U., Gorski, J. R., Muzi, G., and Rozman, K. (1991). Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology, 66, 133–144.
- Gasiewicz, T. A., Holscher, M. A., and Neal, R. A. (1980). The effect of total parenteral nutrition on the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Toxicology and Applied Pharmacology, 54, 469–488.
- DiBartolomeis, M. J., Moore, R. W., Peterson, R. E., Christian, B. J., and Jefcoate, C. R. (1987). Altered regulation of adrenal steroidogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. Biochemical Pharmacology, 36, 59–67.
- Pohjanvirta, R., Laitinen, J., Vakkuri, O., Linden, J., Kokkola, T., Unkila, M., and Tuomisto, J. (1996). Mechanism by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces circulating melatonin levels in the rat. Toxicology, 107, 85–97.
- Moore, R. W., Jefcoate, C. R., and Peterson, R. E. (1991). 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450scc. Toxicology and Applied Pharmacology, 109, 85–97.
- Henry, E. C. and Gasiewicz, T. A. (1987). Changes in thyroid hormones and thyroxine glucuronidation in hamsters compared with rats following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 89, 165–174.
- Kohn, M. C. (2000). Effects of TCDD on thyroid hormone homeostasis in the rat. Drug and Chemical Toxicology, 23, 259–277.
- Niittynen, M., Tuomisto, J. T., Auriola, S., Pohjanvirta, R., Syrjala, P., Simanainen, U., Viluksela, M., and Tuomisto, J. (2003). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced accumulation of biliverdin and hepatic peliosis in rats. Toxicological Sciences, 71, 112–123.
- Mably, T. A., Moore, R. W., and Peterson, R. E. (1992). In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Effects on androgenic status. Toxicology and Applied Pharmacology, 114, 97–107.
- Mably, T. A., Moore, R. W., Goy, R. W., and Peterson, R. E. (1992). In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2. Effects on sexual behavior and the regulation of luteinizing hormone secretion in adulthood. Toxicology and Applied Pharmacology, 114, 108–117.
- Kattainen, H., Tuukkanen, J., Simanainen, U., Tuomisto, J. T., Kovero, O., Lukinmaa, P. L., Alaluusua, S., Tuomisto, J., and Viluksela, M. (2001). In utero/lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure impairs molar tooth development in rats. Toxicology and Applied Pharmacology, 174, 216–224.
- Kransler, K. M., McGarrigle, B. P., and Olson, J. R. (2007). Comparative developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the hamster, rat and guinea pig. Toxicology, 229, 214–225.
- Poland, A. and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology, 22, 517–554.
- Safe, S. H. (1986). Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annual Review of Pharmacology and Toxicology, 26, 371–399.
- Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1996). Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicology and Applied Pharmacology, 140, 173–179.
- Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., and Fujii-Kuriyama, Y. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells, 2, 645–654.
- Vorderstrasse, B. A., Steppan, L. B., Silverstone, A. E., and Kerkvliet, N. I. (2001). Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicology and Applied Pharmacology, 171, 157–164.
- Lin, T. M., Ko, K., Moore, R. W., Simanainen, U., Oberley, T. D., and Peterson, R. E. (2002). Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicological Sciences, 68, 479–487.
- Nishimura, N., Yonemoto, J., Miyabara, Y., Fujii-Kuriyama, Y., and Tohyama, C. (2005). Altered thyroxin and retinoid metabolic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in aryl hydrocarbon receptor-null mice. Archives of Toxicology, 79, 260–267.
- Davies, R., Clothier, B., Robinson, S. W., Edwards, R. E., Greaves, P., Luo, J., Gant, T. W., Chernova, T., and Smith, A. G. (2008). Essential role of the AH receptor in the dys-function of heme metabolism induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chemical Research in Toxicology, 21, 330–340.
- Thurmond, T. S., Silverstone, A. E., Baggs, R. B., Quimby, F. W., Staples, J. E., and Gasiewicz, T. A. (1999). A chimeric aryl hydrocarbon receptor knockout mouse model indicates that aryl hydrocarbon receptor activation in hematopoietic cells contributes to the hepatic lesions induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 158, 33–40.
- Walisser, J. A., Glover, E., Pande, K., Liss, A. L., and Bradfield, C. A. (2005). Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proceedings of the National Academy of Sciences of the United States of America, 102, 17858–17863.
- Kawamata, M. and Ochiya, T. (2010). Generation of genetically modified rats from embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 107, 14223–14228.
- Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., and Bradfield, C. A. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. Journal of Biological Chemistry, 278, 17767–17774.
- Bunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., and Bradfield, C. A. (2008). Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicological Sciences, 106, 83–92.
- Walisser, J. A., Bunger, M. K., Glover, E., Harstad, E. B., and Bradfield, C. A. (2004). Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. Journal of Biological Chemistry, 279, 16326–16331.
- Nukaya, M., Walisser, J. A., Moran, S. M., Kennedy, G. D., and Bradfield, C. A. (2010). Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydro-carbon receptor-mediated adaptive and toxic responses in liver. Toxicological Sciences, 118, 554–563.
- Walisser, J. A., Bunger, M. K., Glover, E., and Bradfield, C. A. (2004). Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proceedings of the National Academy of Sciences of the United States of America, 101, 16677–16682.
- Sciullo, E. M., Dong, B., Vogel, C. F., and Matsumura, F. (2009). Characterization of the pattern of the nongenomic signaling pathway through which TCDD-induces early inflammatory responses in U937 human macrophages. Chemo-sphere, 74, 1531–1537.
- Sciullo, E. M., Vogel, C. F., Li, W., and Matsumura, F. (2008). Initial and extended inflammatory messages of the nongenomic signaling pathway of the TCDD-activated Ah receptor in U937 macrophages. Archives of Biochemistry and Biophysics, 480, 143–155.
- Dong, B. and Matsumura, F. (2009). The conversion of rapid TCCD nongenomic signals to persistent inflammatory effects via select protein kinases in MCF10A cells. Molecular Endocrinology (Baltimore, Md.) 23, 549–558.
- Dong, B. and Matsumura, F. (2008). Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells. Molecular Pharmacology, 74, 255–263.
- Dong, B., Nishimura, N., Vogel, C. F., Tohyama, C., and Matsumura, F. (2010). TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys. Biochemical Pharmacology, 79, 487–497.
- Matsumura, F. (2009). The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochemical Pharmacology, 77, 608–626.
- Nishimura, N., Matsumura, F., Vogel, C. F., Nishimura, H., Yonemoto, J., Yoshioka, W., and Tohyama, C. (2008). Critical role of cyclooxygenase-2 activation in pathogenesis of hydro-nephrosis caused by lactational exposure of mice to dioxin. Toxicology and Applied Pharmacology, 231, 374–383.
- Whitelaw, M. L., Gottlicher, M., Gustafsson, J. A., and Poellinger, L. (1993). Definition of a novel ligand binding domain of a nuclear bHLH receptor: co-localization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor. EMBO Journal, 12, 4169–4179.
- Pongratz, I., Mason, G. G., and Poellinger, L. (1992). Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. Journal of Biological Chemistry, 267, 13728–13734.
- Kazlauskas, A., Sundstrom, S., Poellinger, L., and Pongratz, I. (2001). The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor. Molecular and Cellular Biology, 21, 2594–2607.
- Denison, M. S. and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annual Review of Pharmacology and Toxicology, 43, 309–334.
- Rowlands, J. C., McEwan, I. J., and Gustafsson, J. A. (1996). Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Molecular Pharmacology, 50, 538–548.
- Ma, Q., Dong, L., and Whitlock, J. P., Jr. (1995). Transcriptional activation by the mouse Ah receptor. Interplay between multiple stimulatory and inhibitory functions. Journal of Biological Chemistry, 270, 12697–12703.
- Ko, H. P., Okino, S. T., Ma, Q., and Whitlock, J. P., Jr. (1997). Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo. Molecular and Cellular Biology, 17, 3497–3507.
- Jain, S., Dolwick, K. M., Schmidt, J. V., and Bradfield, C. A. (1994). Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini. Journal of Biological Chemistry, 269, 31518–31524.
- Kumar, M. B., Ramadoss, P., Reen, R. K., Vanden Heuvel, J. P., and Perdew, G. H. (2001). The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity. Journal of Biological Chemistry, 276, 42302–42310.
- Chapman, D. E. and Schiller, C. M. (1985). Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice. Toxicology and Applied Pharmacology, 78, 147–157.
- Birnbaum, L. S., McDonald, M. M., Blair, P. C., Clark, A. M., and Harris, M. W. (1990). Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah Locus. Fundamental and Applied Toxicology, 15, 186–200.
- Kerkvliet, N. I., Baecher-Steppan, L., Smith, B. B., Young-berg, J. A., Henderson, M. C., and Buhler, D. R. (1990). Role of the Ah locus in suppression of cytotoxic T lymphocyte activity by halogenated aromatic hydrocarbons (PCBs and TCDD): structure–activity relationships and effects in C57Bl/ 6 mice congenic at the Ah locus. Fundamental and Applied Toxicology, 14, 532–541.
- Davies, R., Clothier, B., Robinson, S. W., Edwards, R. E., Greaves, P., Luo, J., Gant, T. W., Chernova, T., and Smith, A. G. (2008). Essential role of the AH receptor in the dys-function of heme metabolism induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chemical Research in Toxicology, 21, 330–340.
- Lin, F. H., Clark, G., Birnbaum, L. S., Lucier, G. W., and Goldstein, J. A. (1991). Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Molecular Pharmacology, 39, 307–313.
- Lin, F. H., Stohs, S. J., Birnbaum, L. S., Clark, G., Lucier, G. W., and Goldstein, J. A. (1991). The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicology and Applied Pharmacology, 108, 129–139.
- Poland, A. and Glover, E. (1980). 2,3,7,8-Tetrachlorodibenzo-p-dioxin: segregation of toxicity with the Ah locus. Molecular Pharmacology, 17, 86–94.
- Hong, L. H., McKinney, J. D., and Luster, M. I. (1987). Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated myelotoxicity by thyroid hormones. Biochemical Pharmacology, 36, 1361–1365.
- Mohammadpour, H., Murray, W. J., and Stohs, S. J. (1988). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced lipid peroxidation in genetically responsive and non-responsive mice. Archives of Environmental Contamination and Toxicology, 17, 645–650.
- Clark, G. C., Taylor, M. J., Tritscher, A. M., and Lucier, G. W. (1991). Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated endotoxin hypersensitivity in C57BL/6J mice congenic at the Ah locus. Toxicology and Applied Pharmacology, 111, 422–431.
- Harper, N., Connor, K., and Safe, S. (1993). Immunotoxic potencies of polychlorinated biphenyl (PCB), dibenzofuran (PCDF) and dibenzo-p-dioxin (PCDD) congeners in C57BL/6 and DBA/2 mice. Toxicology, 80, 217–227.
- Beebe, L. E., Fornwald, L. W., Diwan, B. A., Anver, M. R., and Anderson, L. M. (1995). Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice. Cancer Research, 55, 4875–4880.
- Okey, A. B., Vella, L. M., and Harper, P. A. (1989). Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene. Molecular Pharmacology, 35, 823–830.
- Chang, C., Smith, D. R., Prasad, V. S., Sidman, C. L., Nebert, D. W., and Puga, A. (1993). Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics, 3, 312–321.
- Poland, A., Palen, D., and Glover, E. (1994). Analysis of the four alleles of the murine aryl hydrocarbon receptor. Molecular Pharmacology, 46, 915–921.
- Beatty, P. W., Holscher, M. A., and Neal, R. A. (1976). Toxicity of 2, 3,7,8-tetrachlorodibenzo-p-dioxin in larval and adult forms of Rana catesbeiana. Bulletin of Environmental Contamination and Toxicology, 16, 578–581.
- Jung, R. E. and Walker, M. K. (1997). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on development of anuran amphibians. Environmental Toxicology and Chemistry, 16, 230–240.
- Lavine, J. A., Rowatt, A. J., Klimova, T., Whitington, A. J., Dengler, E., Beck, C., and Powell, W. H. (2005). Aryl hydro-carbon receptors in the frog Xenopus laevis: two AhR1 paralogs exhibit low affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicological Sciences, 88, 60–72.
- Yasui, T., Kim, E. Y., Iwata, H., Franks, D. G., Karchner, S. I., Hahn, M. E., and Tanabe, S. (2007). Functional characterization and evolutionary history of two aryl hydrocarbon receptor isoforms (AhR1 and AhR2) from avian species. Toxicological Sciences, 99, 101–117.
- Head, J. A., Hahn, M. E., and Kennedy, S. W. (2008). Key amino acids in the aryl hydrocarbon receptor predict dioxin sensitivity in avian species. Environmental Science & Technology, 42, 7535–7541.
- Manchester, D. K., Gordon, S. K., Golas, C. L., Roberts, E. A., and Okey, A. B. (1987). Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Research, 47, 4861–4868.
- Ramadoss, P. and Perdew, G. H. (2004). Use of 2-azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a probe to determine the relative ligand affinity of human versus mouse aryl hydrocarbon receptor in cultured cells. Molecular Pharmacology, 66, 129–136.
- Flaveny, C. A., Murray, I. A., Chiaro, C. R., and Perdew, G. H. (2009). Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice. Molecular Pharmacology, 75, 1412–1420.
- Denison, M. S. and Wilkinson, C. F. (1985). Identification of the Ah receptor in selected mammalian species and induction of aryl hydrocarbon hydroxylase. European Journal of Biochemistry, 147, 429–435.
- Korkalainen, M., Tuomisto, J., and Pohjanvirta, R. (2000). Restructured transactivation domain in hamster AH receptor. Biochemical and Biophysical Research Communications, 273, 272–281.
- Pohjanvirta, R., Wong, J. M., Li, W., Harper, P. A., Tuomisto, J., and Okey, A. B. (1998). Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydro-carbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Molecular Pharmacology, 54, 86–93.
- Pohjanvirta, R., Viluksela, M., Tuomisto, J. T., Unkila, M., Karasinska, J., Franc, M. A., Holowenko, M., Giannone, J. V., Harper, P. A., Tuomisto, J., and Okey, A. B. (1999). Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains. Toxicology and Applied Pharmacology, 155, 82–95.
- Korkalainen, M., Tuomisto, J., and Pohjanvirta, R. (2001). The AH receptor of the most dioxin-sensitive species, guinea pig, is highly homologous to the human AH receptor. Biochemical and Biophysical Research Communications, 285, 1121–1129.
- Gasiewicz, T. A., Rucci, G., Henry, E. C., and Baggs, R. B. (1986). Changes in hamster hepatic cytochrome P-450, ethoxycoumarin O-deethylase, and reduced NAD(P): menadione oxidoreductase following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Partial dissociation of temporal and dose– response relationships from elicited toxicity. Biochemical Pharmacology, 35, 2737–2742.
- Pohjanvirta, R., Juvonen, R., Karenlampi, S., Raunio, H., and Tuomisto, J. (1988). Hepatic Ah-receptor levels and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hepatic microsomal monooxygenase activities in a TCDD-susceptible and -resistant rat strain. Toxicology and Applied Pharmacology, 92, 131–140.
- Unkila, M., Pohjanvirta, R., Honkakoski, P., Torronen, R., and Tuomisto, J. (1993). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain. Biochemical Pharmacology, 46, 651–659.
- Huuskonen, H., Unkila, M., Pohjanvirta, R., and Tuomisto, J. (1994). Developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-resistant and -susceptible rat strains. Toxicology and Applied Pharmacology, 124, 174–180.
- Pohjanvirta, R., Vartiainen, T., Uusi-Rauva, A., Monkkonen, J., and Tuomisto, J. (1990). Tissue distribution, metabolism, and excretion of 14C-TCDD in a TCDD-susceptible and a TCDD-resistant rat strain. Pharmacology & Toxicology, 66, 93–100.
- Pohjanvirta, R. (1991). Studies on the mechanism of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Thesis, Publications of the National Public Health Institute (NPHI) A1.
- Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Critical Reviews in Toxicology, 21, 51–88.
- Mekenyan, O. G., Veith, G. D., Call, D. J., and Ankley, G. T. (1996). A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. Environmental Health Perspectives, 104, 1302–1310.
- Tuppurainen, K. and Ruuskanen, J. (2000). Electronic eigenvalue (EEVA): a new QSAR/QSPR descriptor for electronic substituent effects based on molecular orbital energies. A QSAR approach to the Ah receptor binding affinity of polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs). Chemosphere, 41, 843–848.
- Pohjanvirta, R., Unkila, M., Linden, J., Tuomisto, J. T., and Tuomisto, J. (1995). Toxic equivalency factors do not predict the acute toxicities of dioxins in rats. European Journal of Pharmacology, 293, 341–353.
- Pohjanvirta, R. (1990). TCDD resistance is inherited as an autosomal dominant trait in the rat. Toxicology Letters, 50, 49–56.
- Tuomisto, J. T., Viluksela, M., Pohjanvirta, R., and Tuomisto, J. (1999). The AH receptor and a novel gene determine acute toxic responses to TCDD: segregation of the resistant alleles to different rat lines. Toxicology and Applied Pharmacology, 155, 71–81.
- Moffat, I. D., Roblin, S., Harper, P. A., Okey, A. B., and Pohjanvirta, R. (2007). Aryl hydrocarbon receptor splice variants in the dioxin-resistant rat: tissue expression and transactivational activity. Molecular Pharmacology, 72, 956–966.
- Korkalainen, M., Tuomisto, J., and Pohjanvirta, R. (2003). Identification of novel splice variants of ARNTand ARNT2 in the rat. Biochemical and Biophysical Research Communications, 303, 1095–1100.
- Korkalainen, M., Tuomisto, J., and Pohjanvirta, R. (2004). Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain. Biochemical and Biophysical Research Communications, 315, 123–131.
- Matsumura, F., Enan, E., Dunlap, D. Y., Pinkerton, K. E., and Peake, J. (1997). Altered in vivo toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C-SRC deficient mice. Biochemical Pharmacology, 53, 1397–1404.
-
Enan, E., Dunlap, D. Y., and Matsumura, F. (1998). Use of c-Src and c-Fos knockout mice for the studies on the role of c-Src kinase signaling in the expression of toxicity of TCDD. Journal of Biochemical and Molecular Toxicology, 12, 263–274.
10.1002/(SICI)1099-0461(1998)12:5<263::AID-JBT2>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- Dunlap, D. Y., Ikeda, I., Nagashima, H., Vogel, C. F., and Matsumura, F. (2002). Effects of src-deficiency on the expression of in vivo toxicity of TCDD in a strain of c-src knockout mice procured through six generations of back-crossings to C57BL/6 mice. Toxicology, 172, 125–141.
- Pohjanvirta, R. (2009). Transgenic mouse lines expressing rat AH receptor variants—a new animal model for research on AH receptor function and dioxin toxicity mechanisms. Toxicology and Applied Pharmacology, 236, 166–182.
- Franc, M. A., Pohjanvirta, R., Tuomisto, J., and Okey, A. B. (2001). In vivo up-regulation of aryl hydrocarbon receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in a dioxin-resistant rat model. Biochemical Pharmacology, 62, 1565–1578.
- Franc, M. A., Pohjanvirta, R., Tuomisto, J., and Okey, A. B. (2001). Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model. Toxicology and Applied Pharmacology, 175, 43–53.
- Franc, M. A., Moffat, I. D., Boutros, P. C., Tuomisto, J. T., Tuomisto, J., Pohjanvirta, R., and Okey, A. B. (2008). Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats. Archives of Toxicology, 82, 809–830.
- Ko, H. P., Okino, S. T., Ma, Q., and Whitlock, J. P., Jr. (1996). Dioxin-induced CYP1A1 transcription in vivo: the aromatic hydrocarbon receptor mediates transactivation, enhancer-promoter communication, and changes in chromatin structure. Molecular and Cellular Biology, 16, 430–436.
- Reen, R. K., Cadwallader, A., and Perdew, G. H. (2002). The subdomains of the transactivation domain of the aryl hydro-carbon receptor (AhR) inhibit AhR and estrogen receptor transcriptional activity. Archives of Biochemistry and Biophysics, 408, 93–102.
- Viluksela, M., Bager, Y., Tuomisto, J. T., Scheu, G., Unkila, M., Pohjanvirta, R., Flodstrom, S., Kosma, V. M., MakiPaakkanen, J., Vartiainen, T., Klimm, C., Schramm, K. W., Warngard, L., and Tuomisto, J. (2000). Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains. Cancer Research, 60, 6911–6920.
- McConnell, E. E., Moore, J. A., Haseman, J. K., and Harris, M. W. (1978). The comparative toxicity of chlorinated dibenzo-p-dioxins in mice and guinea pigs. Toxicology and Applied Pharmacology, 44, 335–356.
- Seefeld, M. D., Corbett, S. W., Keesey, R. E., and Peterson, R. E. (1984). Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 73, 311–322.
- Kelling, C. K., Christian, B. J., Inhorn, S. L., and Peterson, R. E. (1985). Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundamental and Applied Toxicology, 5, 700–712.
- Moore, R. W., Potter, C. L., Theobald, H. M., Robinson, J. A., and Peterson, R. E. (1985). Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 79, 99–111.
- Kleeman, J. M., Moore, R. W., and Peterson, R. E. (1990). Inhibition of testicular steroidogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats: evidence that the key lesion occurs prior to or during pregnenolone formation. Toxicology and Applied Pharmacology, 106, 112–125.
- Gorski, J. R. and Rozman, K. (1987). Dose–response and time course of hypothyroxinemia and hypoinsulinemia and characterization of insulin hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Toxicology, 44, 297–307.
- Bastomsky, C. H. (1977). Enhanced thyroxine metabolism and high uptake goiters in rats after a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Endocrinology, 101, 292–296.
- Weber, L. W., Lebofsky, M., Stahl, B. U., Smith, S., and Rozman, K. K. (1995). Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice. Toxicology and Applied Pharmacology, 131, 155–162.
- Gorski, J. R., Muzi, G., Weber, L. W., Pereira, D. W., Arceo, R. J., Iatropoulos, M. J., and Rozman, K. (1988). Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicologic Pathology, 16, 313–320.
- Novelli, M., Piaggi, S., and De Tata, V. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced impairment of glucose-stimulated insulin secretion in isolated rat pancreatic islets. Toxicology Letters, 156, 307–314.
- Bestervelt, L. L., Cai, Y., Piper, D. W., Nolan, C. J., Pitt, J. A., and Piper, W. N. (1993). TCDD alters pituitary–adrenal function. I: Adrenal responsiveness to exogenous ACTH. Neurotoxicology and Teratology, 15, 365–367.
- Potter, C. L., Moore, R. W., Inhorn, S. L., Hagen, T. C., and Peterson, R. E. (1986). Thyroid status and thermogenesis in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 84, 45–55.
- Pohjanvirta, R., Unkila, M., Tuomisto, J. T., Vuolteenaho, O., Leppaluoto, J., and Tuomisto, J. (1993). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on plasma and tissue beta-endorphin-like immunoreactivity in the most TCDD-susceptible and the most TCDD-resistant rat strain. Life Sciences, 53, 1479–1487.
- Potter, C. L., Sipes, I. G., and Russell, D. H. (1983). Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration. Toxicology and Applied Pharmacology, 69, 89–95.
- Pohjanvirta, R., Kulju, T., Morselt, A. F., Tuominen, R., Juvonen, R., Rozman, K., Mannisto, P., Collan, Y., Sainio, E. L., and Tuomisto, J. (1989). Target tissue morphology and serum biochemistry following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain. Fundamental and Applied Toxicology, 12, 698–712.
- Fletcher, N., Wahlstrom, D., Lundberg, R., Nilsson, C. B., Nilsson, K. C., Stockling, K., Hellmold, H., and Hakansson, H. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicology and Applied Pharmacology, 207, 1–24.
- Simanainen, U., Tuomisto, J. T., Tuomisto, J., and Viluksela, M. (2003). Dose–response analysis of short-term effects of 2,3,7, 8-tetrachlorodibenzo-p-dioxin in three differentially susceptible rat lines. Toxicology and Applied Pharmacology, 187, 128–136.
- Cantoni, L., Rizzardini, M., Graziani, A., Carugo, C., and Garattini, S. (1987). Effects of chlorinated organics on intermediates in the heme pathway and on uroporphyrinogen decarboxylase. Annals of the New York Academy of Sciences, 514, 128–140.
- Cantoni, L., Salmona, M., and Rizzardini, M. (1981). Porphyrogenic effect of chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats. Dose–effect relationship following urinary excretion of porphyrins. Toxicology and Applied Pharmacology, 57, 156–163.
- Pelclova, D., Urban, P., Preiss, J., Lukas, E., Fenclova, Z., Navratil, T., Dubska, Z., and Senholdova, Z. (2006). Adverse health effects in humans exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Reviews on Environmental Health, 21, 119–138.
- Zinkl, J. G., Vos, J. G., Moore, J. A., and Gupta, B. N. (1973). Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environmental Health Perspectives, 5, 111–118.
- Yang, K. H., Yoo, B. S., and Choe, S. Y. (1983). Effects of halogenated dibenzo-p-dioxins on plasma disappearance and biliary excretion of ouabain in rats. Toxicology Letters, 15, 259–264.
- Fletcher, N., Hanberg, A., and Hakansson, H. (2001). Hepatic vitamin A depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species. Toxicological Sciences, 62, 166–175.
- Yang, Y. M., Huang, D. Y., Liu, G. F., Zhong, J. C., Du, K., Li, Y. F., and Song, X. H. (2005). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A metabolism in mice. Journal of Biochemical and Molecular Toxicology, 19, 327–335.
- Passarini, B., Infusino, S. D., and Kasapi, E. (2010). Chlor-acne: still cause for concern. Dermatology (Basel, Switzerland), 221, 63–70.
- McNulty, W. P., Pomerantz, I., and Farrell, T. (1981). Chronic toxicity of 2,3,7,8-tetrachlorodibenzofuran for rhesus macaques. Food and Cosmetics Toxicology, 19, 57–65.
- Vos, J. G., Van Leeuwen, F.X., and de Jong, P. (1982). Acnegenic activity of 3-methylcholanthrene and benzo[a] pyrene, and a comparative study with 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rabbit and hairless mouse. Toxicology, 23, 187–196.
- Jones, G. and Greig, J. B. (1975). Pathological changes in the liver of mice given 2,3,7,8-tetrachlorodibenzo-p-dioxin. Experientia, 31, 1315–1317.
- Jones, G. and Butler, W. H. (1974). A morphological study of the liver lesion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Journal of Pathology, 112, 93–97.
- Vos, J. G. and Beems, R. B. (1971). Dermal toxicity studies of technical polychlorinated biphenyls and fractions thereof in rabbits. Toxicology and Applied Pharmacology, 19, 617–633.
- Chahoud, I., Hartmann, J., Rune, G. M., and Neubert, D. (1992). Reproductive toxicity and toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects of single doses on the testis of male rats. Archives of Toxicology, 66, 567–572.
- Johnson, L., Dickerson, R., Safe, S. H., Nyberg, C. L., Lewis, R. P., and Welsh, T. H., Jr. (1992). Reduced Leydig cell volume and function in adult rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin without a significant effect on spermato-genesis. Toxicology, 76, 103–118.
- Jokinen, M. P., Walker, N. J., Brix, A. E., Sells, D. M., Haseman, J. K., and Nyska, A. (2003). Increase in cardiovascular pathology in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3′,4,4′,5-pentachlorobiphenyl. Cardiovascular Toxicology, 3, 299–310.
- Murante, F. G. and Gasiewicz, T. A. (2000). Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice. Toxicological Sciences, 54, 374–383.
- Moos, A. B., Baecher-Steppan, L., and Kerkvliet, N. I. (1994). Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF. Toxicology and Applied Pharmacology, 127, 331–335.
- Fan, F., Yan, B., Wood, G., Viluksela, M., and Rozman, K. K. (1997). Cytokines (IL-1β and TNFα) in relation to biochemical and immunological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology, 116, 9–16.
- Kim, H. J., Jeong, K. S., Park, S. J., Cho, S. W., Son, H. Y., Kim, S. R., Kim, S. H., An, M. Y., and Ryu, S. Y. (2003). Effects of benzo[alpha]pyrene, 2-bromopropane, phenol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on IL-6 production in mice after single or repeated exposure. In Vivo (Athens, Greece), 17, 269–275.
- Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., and Weiner, H. L. (2008). Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature, 453, 65–71.
- Abbott, B. D. and Birnbaum, L. S. (1990). TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicology and Applied Pharmacology, 106, 418–432.
- Dohr, O., Vogel, C., and Abel, J. (1994). Modulation of growth factor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Experimental and Clinical Immunogenetics, 11, 142–148.
- Kakeyama, M., Sone, H., and Tohyama, C. (2001). Changes in expression of NMDA receptor subunit mRNA by perinatal exposure to dioxin. Neuroreport, 12, 4009–4012.
- Widholm, J. J., Seo, B. W., Strupp, B. J., Seegal, R. F., and Schantz, S. L. (2003). Effects of perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on spatial and visual reversal learning in rats. Neurotoxicology and Teratology, 25, 459–471.
- Schantz, S. L. and Bowman, R. E. (1989). Learning in monkeys exposed perinatally to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Neurotoxicology and Teratology, 11, 13–19.
- Aragon, A. C., Kopf, P. G., Campen, M. J., Huwe, J. K., and Walker, M. K. (2008). In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology. Toxicological Sciences, 101, 321–330.
- Rao, M. S., Subbarao, V., Prasad, J. D., and Scarpelli, D. G. (1988). Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Syrian golden hamster. Carcinogenesis, 9, 1677–1679.
- Pohjanvirta, R., Hakansson, H., Juvonen, R., and Tuomisto, J. (1990). Effects of TCDD on vitamin A status and liver microsomal enzyme activities in a TCDD-susceptible and a TCDD-resistant rat strain. Food and Chemical Toxicology, 28, 197–203.
- Pohjanvirta, R., Hirvonen, M. R., Unkila, M., Savolainen, K., and Tuomisto, J. (1994). TCDD decreases brain inositol concentrations in the rat. Toxicology Letters, 70, 363–372.
- Unkila, M., Pohjanvirta, R., MacDonald, E., and Tuomisto, J. (1993). Differential effect of TCDD on brain serotonin metabolism in a TCDD-susceptible and a TCDD-resistant rat strain. Chemosphere, 27, 401–406.
- Pohjanvirta, R., Sankari, S., Kulju, T., Naukkarinen, A., Ylinen, M., and Tuomisto, J. (1990). Studies on the role of lipid peroxidation in the acute toxicity of TCDD in rats. Pharmacology & Toxicology, 66, 399–408.
- Pohjanvirta, R., Tuomisto, J., Linden, J., and Laitinen, J. (1989). TCDD reduces serum melatonin levels in Long–Evans rats. Pharmacology & Toxicology, 65, 239–240.
- Linden, J., Pohjanvirta, R., Rahko, T., and Tuomisto, J. (1991). TCDD decreases rapidly and persistently serum melatonin concentration without morphologically affecting the pineal gland in TCDD-resistant Han/Wistar rats. Pharmacology & Toxicology, 69, 427–432.
- Viluksela, M., Unkila, M., Pohjanvirta, R., Tuomisto, J. T., Stahl, B. U., Rozman, K. K., and Tuomisto, J. (1999). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains. Archives of Toxicology, 73, 323–336.
- Tuomisto, J. T., Viluksela, M., Pohjanvirta, R., and Tuomisto, J. (2000). Changes in food intake and food selection in rats after 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure. Pharmacology, Biochemistry, and Behavior, 65, 381–387.
- Niittynen, M., Tuomisto, J. T., Auriola, S., Pohjanvirta, R., Syrjala, P., Simanainen, U., Viluksela, M., and Tuomisto, J. (2003). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced accumulation of biliverdin and hepatic peliosis in rats. Toxicological Sciences, 71, 112–123.
